Itron (ITRI) Declines More Than Market: Some Information for Investors

Itron (ITRI) recently closed down 1.29%, underperforming the broader market, and has significantly lagged the Computer and Technology sector over the past month. Ahead of its upcoming earnings report, consensus estimates project a Q2 EPS decline of 19.57% to $1.48 and a revenue decrease of 6.34% to $576.45 million year-over-year. Despite these near-term projections, the company holds a Zacks Rank #2 (Buy) and trades at a forward P/E of 20.85 and a PEG ratio of 0.69, both at a discount to its industry averages, potentially indicating value within its top-tier Electronics - Testing Equipment industry.

Analysis

Itron (ITRI) presents a conflicting profile for investors, marked by near-term operational headwinds against a backdrop of positive valuation and ranking indicators. The stock's recent performance has been weak, with a 1.29% daily loss and a mere 0.53% gain over the past month, significantly underperforming the Computer and Technology sector's 8.98% rally. This bearish sentiment is reinforced by consensus estimates for the forthcoming earnings report, which project a 19.57% year-over-year decline in EPS to $1.48 and a 6.34% drop in revenue to $576.45 million. However, the full-year outlook is more constructive, forecasting a 6.41% increase in EPS despite a 2.76% revenue contraction, suggesting potential margin expansion or a back-half recovery. Contrasting the negative performance and quarterly outlook, ITRI holds a Zacks Rank of #2 (Buy) and operates within an industry ranked in the top 10% of over 250. Furthermore, the company's valuation appears attractive; its forward P/E of 20.85 is below its industry's average of 23.46, and its PEG ratio of 0.69 is substantially lower than the industry's 2.68, indicating the stock may be undervalued relative to its growth prospects.

Key Decisions for Investors

• Investors should weigh the significant near-term risk posed by the upcoming earnings report, where consensus projects steep declines in quarterly revenue and EPS, against the stock's attractive valuation metrics, particularly its low PEG ratio of 0.69.
• Given the stock's recent underperformance relative to its sector, momentum-focused investors may wish to remain on the sidelines until the company demonstrates it can reverse the negative quarterly trends and deliver on its full-year EPS growth forecast of 6.41%.
• For value-oriented investors, the combination of a Zacks #2 (Buy) rank, a top-tier industry ranking, and a valuation discount to peers could present a strategic entry point, assuming a long-term thesis that is not derailed by the anticipated short-term weakness.